Laser zaps away lichen sclerosus symptoms in new trial

NCT ID NCT06389071

Recruiting now Disease control Sponsor: Sciton Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a fractional 2940 nm laser to treat lichen sclerosus lesions in 50 women aged 18 and older. The laser aims to reduce symptoms like itching, burning, and painful intercourse by removing damaged tissue and promoting healing. Researchers will check tissue samples 16 weeks after treatment to see if the skin has improved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fractional 2940 nm laser
What this could lead to: If it works, this could offer a non-surgical option to ease symptoms like itching, pain, and tearing in women with lichen sclerosus.
What could go wrong: This is an early study with only 50 participants and no comparison group, so results may not apply widely. Laser treatment may cause temporary discomfort or not improve symptoms for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LICHEN SCLEROSUS LESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lichen sclerosus et atrophicus vulvar lichen sclerosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LICHEN SCLEROSUS LESION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Clinique Medicale Uro-Gyneco de l'Abitibi
RECRUITING

Val-d'Or, Quebec, J9P1W1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.